168 related articles for article (PubMed ID: 18670273)
1. Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions.
Horikawa Y; Gu J; Wu X
Curr Opin Urol; 2008 Sep; 18(5):493-8. PubMed ID: 18670273
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
[TBL] [Abstract][Full Text] [Related]
3. Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression.
Malats N
Scand J Urol Nephrol Suppl; 2008 Sep; (218):131-40. PubMed ID: 18815927
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology of DNA repair genes in bladder cancer.
Kiltie AE
Methods Mol Biol; 2009; 472():281-306. PubMed ID: 19107438
[TBL] [Abstract][Full Text] [Related]
5. Tests for gene-environment interaction from case-control data: a novel study of type I error, power and designs.
Mukherjee B; Ahn J; Gruber SB; Rennert G; Moreno V; Chatterjee N
Genet Epidemiol; 2008 Nov; 32(7):615-26. PubMed ID: 18473390
[TBL] [Abstract][Full Text] [Related]
6. Improving strategies for detecting genetic patterns of disease susceptibility in association studies.
Calle ML; Urrea V; Vellalta G; Malats N; Steen KV
Stat Med; 2008 Dec; 27(30):6532-46. PubMed ID: 18837071
[TBL] [Abstract][Full Text] [Related]
7. A maximum likelihood method for studying gene-environment interactions under conditional independence of genotype and exposure.
Cheng KF
Stat Med; 2006 Sep; 25(18):3093-109. PubMed ID: 16463309
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
[TBL] [Abstract][Full Text] [Related]
9. Gene-environment interactions in cancer: do they exist?
Hemminki K; Försti A; Bermejo JL
Ann N Y Acad Sci; 2006 Sep; 1076():137-48. PubMed ID: 17119199
[TBL] [Abstract][Full Text] [Related]
10. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions.
Manuguerra M; Matullo G; Veglia F; Autrup H; Dunning AM; Garte S; Gormally E; Malaveille C; Guarrera S; Polidoro S; Saletta F; Peluso M; Airoldi L; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulos D; Kalandidi A; Palli D; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Pera G; Martinez C; Amiano P; Barricarte A; Tormo MJ; Quiros JR; Berglund G; Janzon L; Jarvholm B; Day NE; Allen NE; Saracci R; Kaaks R; Ferrari P; Riboli E; Vineis P
Carcinogenesis; 2007 Feb; 28(2):414-22. PubMed ID: 16956909
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association studies in bladder cancer: first results and potential relevance.
Kiemeney LA; Grotenhuis AJ; Vermeulen SH; Wu X
Curr Opin Urol; 2009 Sep; 19(5):540-6. PubMed ID: 19553824
[TBL] [Abstract][Full Text] [Related]
12. Environmental factors and genetic susceptibility promote urinary bladder cancer.
Volanis D; Kadiyska T; Galanis A; Delakas D; Logotheti S; Zoumpourlis V
Toxicol Lett; 2010 Mar; 193(2):131-7. PubMed ID: 20051252
[TBL] [Abstract][Full Text] [Related]
13. [Application of multifactor dimensionality reduction on the interactions between gene-gene, gene-environment and the risk sporadic colorectal cancer in Chinese population].
Jin MJ; Liu B; Zhang SS; Zhang YJ; Xu M; Ma XY; Yao KY; Chen K
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):535-9. PubMed ID: 19040031
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk.
Lao T; Gu W; Huang Q
Mutagenesis; 2008 Nov; 23(6):523-32. PubMed ID: 18765423
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Oliveira E; Marrakchi R; Cherni L; Ben Othman F; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; Prata MJ; Benammar Elgaaied A
Cancer Genet Cytogenet; 2009 Nov; 195(1):43-53. PubMed ID: 19837268
[TBL] [Abstract][Full Text] [Related]
17. [Using MSR model to analyze the impact of gene-gene interaction with related to the genetic polymorphism of metabolism enzymes on the risk of breast cancer].
Li JY; Long QM; Tao P; Hu R; Li H; Lei FM; Zhou WD; Li SF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):780-3, 787. PubMed ID: 19024313
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and genetic susceptibility to bladder cancer.
Wu X; Ros MM; Gu J; Kiemeney L
BJU Int; 2008 Nov; 102(9 Pt B):1207-15. PubMed ID: 19035883
[TBL] [Abstract][Full Text] [Related]
19. Hereditary bladder cancer.
Kiemeney LA
Scand J Urol Nephrol Suppl; 2008 Sep; (218):110-5. PubMed ID: 18815925
[TBL] [Abstract][Full Text] [Related]
20. Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response.
Grotenhuis AJ; Vermeulen SH; Kiemeney LA
Future Oncol; 2010 Sep; 6(9):1433-60. PubMed ID: 20919828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
